LLY

1,024.63

-0.71%↓

JNJ

240.77

+0.94%↑

ABBV

221.51

-1.29%↓

NVS

159.95

+1.01%↑

MRK

118.67

+1.51%↑

LLY

1,024.63

-0.71%↓

JNJ

240.77

+0.94%↑

ABBV

221.51

-1.29%↓

NVS

159.95

+1.01%↑

MRK

118.67

+1.51%↑

LLY

1,024.63

-0.71%↓

JNJ

240.77

+0.94%↑

ABBV

221.51

-1.29%↓

NVS

159.95

+1.01%↑

MRK

118.67

+1.51%↑

LLY

1,024.63

-0.71%↓

JNJ

240.77

+0.94%↑

ABBV

221.51

-1.29%↓

NVS

159.95

+1.01%↑

MRK

118.67

+1.51%↑

LLY

1,024.63

-0.71%↓

JNJ

240.77

+0.94%↑

ABBV

221.51

-1.29%↓

NVS

159.95

+1.01%↑

MRK

118.67

+1.51%↑

Search

ResMed Inc

Fechado

SetorSaúde

256.79 -5.94

Visão Geral

Variação de preço das ações

24h

Atual

Mín

262.37

Máximo

274.79

Indicadores-chave

By Trading Economics

Rendimento

44M

393M

Vendas

87M

1.4B

P/E

Médio do Setor

25.197

84.243

Rendimento de Dividendos

0.87

Margem de lucro

27.593

Funcionários

10,600

EBITDA

63M

566M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+8.94% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.87%

2.28%

Próximos Ganhos

22 de abr. de 2026

Próxima data de dividendos

19 de mar. de 2026

Próxima data de ex-dividendo

12 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-107M

37B

Abertura anterior

262.73

Fecho anterior

256.79

Sentimento de Notícias

By Acuity

37%

63%

111 / 352 Ranking em Healthcare

ResMed Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

10 de fev. de 2026, 23:26 UTC

Grandes Movimentos do Mercado

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 de fev. de 2026, 22:31 UTC

Ganhos

Correction to America Movil 4Q Profit Article

10 de fev. de 2026, 22:22 UTC

Ganhos

America Movil 4Q Profit Jumps on Lower Financial Costs

10 de fev. de 2026, 23:51 UTC

Conversa de Mercado
Ganhos

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 de fev. de 2026, 23:42 UTC

Conversa de Mercado

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 de fev. de 2026, 23:40 UTC

Conversa de Mercado
Ganhos

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 de fev. de 2026, 23:21 UTC

Conversa de Mercado

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 de fev. de 2026, 23:21 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

10 de fev. de 2026, 22:17 UTC

Conversa de Mercado

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 de fev. de 2026, 22:15 UTC

Ganhos

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 de fev. de 2026, 22:10 UTC

Ganhos

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 de fev. de 2026, 22:10 UTC

Ganhos

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 de fev. de 2026, 22:09 UTC

Ganhos

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 de fev. de 2026, 22:09 UTC

Ganhos

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 de fev. de 2026, 22:01 UTC

Ganhos

Intact Financial 4Q EPS C$5.24 >IFC.T

10 de fev. de 2026, 21:54 UTC

Ganhos

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 de fev. de 2026, 21:53 UTC

Ganhos

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 de fev. de 2026, 21:51 UTC

Ganhos

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 de fev. de 2026, 21:51 UTC

Ganhos

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 de fev. de 2026, 21:51 UTC

Ganhos

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 de fev. de 2026, 21:51 UTC

Ganhos

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 de fev. de 2026, 21:51 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 de fev. de 2026, 21:50 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 de fev. de 2026, 21:50 UTC

Ganhos

James Hardie Industries 3Q EPS 12c >JHX

10 de fev. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

10 de fev. de 2026, 21:50 UTC

Ganhos

James Hardie Industries 3Q Adj EPS 24c >JHX

10 de fev. de 2026, 21:49 UTC

Ganhos

James Hardie Industries 3Q Sales $1.24B >JHX

10 de fev. de 2026, 21:49 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 de fev. de 2026, 21:48 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 de fev. de 2026, 21:47 UTC

Ganhos
Aquisições, Fusões, Aquisições de Empresas

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Comparação entre Pares

Variação de preço

ResMed Inc Previsão

Preço-alvo

By TipRanks

8.94% parte superior

Previsão para 12 meses

Média 300.64 USD  8.94%

Máximo 345 USD

Mínimo 265 USD

Com base em 13 analistas de Wall Street que oferecem metas de preço de 12 meses para ResMed Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

13 ratings

8

Comprar

5

Manter

0

Vender

Sentimento

By Acuity

111 / 352 Ranking em Saúde

Sentimento de Notícias

Evidência de Tendência de Alta

Volatilidade

Abaixo da média

Volume de Notícias (RCV)

Acima da média

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat